| Ticker | FOLD |
|---|---|
| ISIN | US03152W1099 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN...
El precio actual de Amicus Therapeutics, Inc. (FOLD) es de 14,49 , con una variación del 0,21%.
Amicus Therapeutics, Inc. opera en el sector Healthcare, industria Biotechnology.